Latest filing published 26 Jul 2025 for AlzeCure Pharma AB, €4,465.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Pontus Forsell: trading record in brief
Pontus Forsell appears in our data through filings on AlzeCure Pharma AB shares, published by Finansinspektionen. Between 19 January 2021 and 23 July 2025, the trades on record add up to 5 filings.
On the open market, the record shows 3 purchases worth €29k and 1 sale. The amount is not disclosed for 1 filing. Unlike grants, an open-market purchase is paid for by the insider, at the market price. In 2025 alone, the filings show 1 purchase and no sales.
The median purchase comes to €6,496.
Most recently, on 26 July 2025, the filings show an open-market purchase worth €4,465 in AlzeCure Pharma AB. Between a trade and the moment it shows up on Finansinspektionen, the median delay is 3 days. The legal deadline for notifying a trade is three business days (MAR article 19). Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.
Companies and markets linked to Pontus Forsell
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 22,727 shares@ SEK 2.20BTA (betald tecknad aktie)ISIN SE0017563208FI:csv-c4bb802a7099b7ec6e2dCanonical exit: 21 Oct 2025 (T+90)
- 44,500 shares@ SEK 1.7012.6% of flowBTA (betald tecknad aktie)ISIN SE0022060794FI:csv-97eb59c477b5b0c671ceCanonical exit: 15 Aug 2024 (T+90)
- 13,334 shares@ SEK 3.758.7% of flowBTA (betald tecknad aktie)ISIN SE0010133785FI:csv-313d494fd8ceb8c47636
- 806,143 shares0Teckningsrätt/UniträttISIN SE0019174079FI:csv-03618260c0c5c565929b
- 20,000 shares@ SEK 8.9743.6% of flowAktieISIN SE0010133785FI:A001P627-1Canonical exit: 19 Apr 2021 (T+90)
5 of 5 declarations